article thumbnail

Cancer-Causing Culprits Will Be Caught By Their DNA Fingerprints

Drug Discovery Today

Causes of cancer are being catalogued by a huge international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development.

DNA 100
article thumbnail

AI reveals prostate cancer is not just one disease

Drug Discovery World

The researchers analysed the DNA of prostate cancer samples in 159 patients using whole genome sequencing and used an AI technique known as neural networks to compare the different samples. This study is really important because until now, we thought that prostate cancer was just one type of disease.

Disease 148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shervin Tabrizi

Broad Institute

His work focuses on developing novel technologies to improve the performance of liquid biopsies for cancer detection, using approaches in protein engineering to create agents that can improve the recovery of cell-free DNA from the body. Tabrizi earned his M.D.

article thumbnail

Ancient viruses may hold key to gene therapy treatments

Drug Discovery World

It was led by scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) and University of Massachusetts Chan Medical School. . In the study, researchers used ‘fossilised’ virus DNA sequences contained within animal genomes to reconstruct the long-term evolutionary history of parvoviruses.

Virus 130
article thumbnail

Podcast: The impact of synthetic biology and collaboration in pharma

Drug Discovery World

In the second article, Dr David Walt, a professor at Harvard Medical School who runs labs at both Brigham and Women’s Hospital and the Wyss Institute at Harvard University, shares his thoughts on the drug discovery industry and what the pandemic has taught us about lab automation.

article thumbnail

Gerstner Center for Cancer Diagnostics receives additional commitment from Louis V. Gerstner, Jr., to advance technologies that could transform cancer care

Broad Institute

Liquid biopsies enable clinicians to find and analyze tumor DNA in a patient’s blood sample to detect cancer early, monitor cancer recurrence, assess the patient’s response to treatment, and measure other clinically important features in real time, without invasive procedures. "We

DNA 116
article thumbnail

Decoding diseases: The AI renaissance in clinical trials

Drug Discovery World

AI-enabled tumour profiling Furthermore, scientists from Harvard Medical School 8 have pioneered an AI tool named CHARM (Cryosection Histopathology Assessment and Review Machine), which deciphers the DNA of brain tumours in real-time during surgery. Harvard Medical School, 7 July 2023.